Skip to content

Hard Corner Land - 3.5 Acres in Baytown

, NEC N Main St & Blue Heron ParkwayBaytown, TX 77521

Property Highlights & Information

  • Up to 3.5 Acres situated on hard corner of lighted intersection
  • Hard corner on a high-growth signalized intersection in north Baytown's primary growth corridor, with dual frontage on N Main St (±23,200 VPD) and Blue Heron Pkwy.
  • Development momentum on every corner: ClearSky Health's 40,000 SF, 30-bed rehabilitation hospital is sited at Blue Heron & N Main, and a $25M luxury senior living + retail PUD was approved just southeast at 4300 N Main — proven institutional demand at this intersection.
  • Pro-development zoning environment: the City of Baytown initiated a city-sponsored rezoning of the Blue Heron Parkway corridor specifically to allow commercial development without SUP or rezoning hurdles — reduced entitlement risk and faster speed to market.
  • Rooftops driving retail demand: ~2,000 new homes announced or under construction across Baytown, with active subdivisions (e.g., Blue Heron Estates) feeding the immediate trade area.
  • Regional connectivity: minutes to I-10, SH 146, and the Grand Parkway (SH 99), whose eastern segments terminate in Baytown — positioning the site on the path of Houston's eastward growth.
  • Employment-anchored trade area: Baytown is home to ExxonMobil's Baytown Complex (the largest U.S. refinery), Chevron Phillips Chemical, and Covestro. Ongoing multi-billion-dollar expansions — including Exxon's reconfiguration project targeting 2028 startup — are projected to add ~1,000 permanent and 11,000+ construction jobs.


Land Available: 3.50 Acres

Available Opportunities

For Sale 3.5 Acres Pad Site

Demographic Information

Population (3m)67,354
Average Household Income (3m)$85,046
Traffic CountW Barker: 15,164 VPD (Source: TxDot)

Location

Brokers

Safin Momin
Commercial Advisor
Jessica Roman
Junior Associate
Martin Turner
Executive Chairman & CFO

Request More Information

Request More Information

Receive the latest news

SUBSCRIBE HERE

Personal information remains confidential